Premal H. Thaker

10.4k citations

283 papers · 5.5k indexed · h-index 39

Impact in

Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment

Papers in

Reproductive Medicine 98
- Ovarian cancer diagnosis and treatment 85
Obstetrics and Gynecology 88
- Endometrial and Cervical Cancer Treatments 83
- Uterine Myomas and Treatments 18

Co-authors: Anil K. Sood David G. Mutch Susan K. Lutgendorf Matthew A. Powell Israel Zighelboim Charles N. Landen L. Stewart Massad Steve W. Cole
Journals: Gynecologic Oncology (102 papers)Journal of Clinical Oncology (31 papers)International Journal of Gynecological Cancer (13 papers)Cancer (11 papers)Cancer Research (10 papers)
Partner nations: United States United Kingdom Italy

In The Last Decade

Premal H. Thaker

257 papers receiving 5.4k citations

Peers

Countries citing papers authored by Premal H. Thaker

Since Specialization

Citations

This map shows the geographic impact of Premal H. Thaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Premal H. Thaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Premal H. Thaker more than expected).

Fields of papers citing papers by Premal H. Thaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Premal H. Thaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Premal H. Thaker. The network helps show where Premal H. Thaker may publish in the future.

Co-authors

The 25 scholars most cited alongside Premal H. Thaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Premal H. Thaker Line = papers co-authored together Premal H. Thaker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy–Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response Cancer Research ·Mark C. Valentine, Mary M. Mullen, Emilee N. Kotnik, Matthew A. Powell, Premal H. Thaker, Carolyn K. McCourt, Lindsay M. Kuroki, Andrea R. Hagemann, Rebecca C. Arend, Alex S. Holehouse, Robi D. Mitra, David G. Mutch, Katherine C. Fuh	2025	1
2	Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis Gynecologic Oncology ·Ayesha B. Alvero, Sharon Wu, Alex Farrell, Seongho Kim, John Wallbillich, Ira Winer, Robert E. Morris, David Spetzler, Matthew L. Anderson, Alberto Puccini, Nathaniel Jones, Thomas J. Herzog, Premal H. Thaker, Gil Mor, Radhika Gogoi	2025	2
3	Prophylactic antibiotics for excision of premalignant vulvar lesions: A pilot randomized controlled trial Gynecologic Oncology Reports ·Mary Mullen, Whitney R. Grither, Hannah Millimet, David G. Mutch, Andrea R. Hagemann, Carolyn K. McCourt, Matthew A. Powell, Premal H. Thaker, Dineo Khabele, Lindsay M. Kuroki	2024	0
4	Abstract PO4-10-10: NAVYA-AI enabled intervention to increase real-world guideline compliant care: Improving NGS testing in breast cancer Cancer Research ·RA Badwe, Premal H. Thaker, Farzana Begum, Mayukh Acherjee, Gitika Srivastava, Naresh Ramarajan, Shona Nag, Sudeep Gupta, Seema Gulia, Jaya Ghosh, Bhawna Sirohi	2024	0
5	Improving diverse patient enrollment in clinical trials, focusing on Hispanic and Asian populations: recommendations from an interdisciplinary expert panel International Journal of Gynecological Cancer ·Bhavana Pothuri, Premal H. Thaker, Adrienne Moore, Rosa María Ortiz Espinosa, Kara Medina, Deborah Collyar, Kathleen Lutz, Mihaela Munteanu, Brian M. Slomovitz	2024	4
6	When a synonymous mutation breaks the silence in a thalassaemia patient British Journal of Haematology ·Manju Gorivale, Pratibha Sawant, Neha Kargutkar, Priya Hariharan, Premal H. Thaker, Ashish Chiddarwar, Anita Nadkarni	2023	1
7	Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival Communications Biology ·Emilee N. Kotnik, Mary M. Mullen, Nicholas C. Spies, Tiandao Li, Matthew Inkman, Jin Zhang, Fernanda Martins Rodrigues, Ian S. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Andrea R. Hagemann, Matthew A. Powell, David G. Mutch, Dineo Khabele, Gregory D. Longmore, Elaine R. Mardis, Christopher A. Maher, Christopher A. Miller, Katherine C. Fuh	2023	18
8	Historic Clinical Trial External Control Arm Provides Actionable GEN-1 Efficacy Estimate Before a Randomized Trial JCO Clinical Cancer Informatics ·Xiang Yin, Ruthanna Davi, Elizabeth B. Lamont, Premal H. Thaker, William H. Bradley, Charles A. Leath, Kathleen N. Moore, Khursheed Anwer, Lauren Musso, Nicholas Borys	2023	7
9	MODY5 and Serous Ovarian Carcinoma in 17q12 Recurrent Deletion Syndrome AACE Clinical Case Reports ·Aswathi Kumar, Laura Hollar, Janet B. McGill, Premal H. Thaker, Maamoun Salam	2023	1
10	GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis Molecular Cancer Therapeutics ·Shaina F. Bruce, Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth Stock, Alyssa Oplt, Barbara Blachut, Mary M. Mullen, Lindsay M. Kuroki, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Dineo Khabele, Matthew A. Powell, David G. Mutch, Leah P. Shriver, Gary J. Patti, Katherine C. Fuh	2022	10
11	GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study Clinical Cancer Research ·Premal H. Thaker, William H. Bradley, Charles A. Leath, Camille Gunderson Jackson, Nicholas Borys, Khursheed Anwer, Lauren Musso, Junko Matsuzaki, Wiam Bshara, Kunle Odunsi, Ronald D. Alvarez	2021	19
12	Positive Psychosocial Factors and Oxytocin in the Ovarian Tumor Microenvironment Psychosomatic Medicine ·Michaela G. Cuneo, Angela Szeto, Andrew Schrepf, Premal H. Thaker, Michael J. Goodheart, Steve W. Cole, Anil K. Sood, Philip M. McCabe, Armando J. Mendez, Susan K. Lutgendorf	2021	4
13	Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation Cell Death and Disease ·Pooja Popli, Megan M. Richters, Sangappa B. Chadchan, Tae Hoon Kim, Eric Tycksen, Obi L. Griffith, Premal H. Thaker, Malachi Griffith, Ramakrishna Kommagani	2020	39
14	Continuous epidural infusion in gynecologic oncology patients undergoing exploratory laparotomy: The new standard for decreased postoperative pain and opioid use Gynecologic Oncology ·Sarah P. Huepenbecker, S.E. Cusworth, Lindsay M. Kuroki, Patricia Lu, Christelle D. K. Samen, Candice Woolfolk, Rosa Deterding, Leping Wan, Daniel L. Helsten, Michael M. Bottros, David G. Mutch, Matthew A. Powell, L. Stewart Massad, Premal H. Thaker	2019	7
15	Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer Molecular Cancer Therapeutics ·Jeanne M. Quinn, Molly M. Greenwade, M. Palisoul, Gregory Opara, Katina Massad, Lei Guo, Peinan Zhao, Hollie Beck-Noia, Ian S. Hagemann, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Matthew A. Powell, David G. Mutch, Katherine C. Fuh	2018	38
16	Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer Molecular Cancer Therapeutics ·M. Palisoul, Jeanne M. Quinn, Emily Schepers, Ian S. Hagemann, Lei Guo, Kelsey Reger, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Matthew A. Powell, David G. Mutch, Katherine C. Fuh	2017	24
17	Stress and Burnout Among Gynecologic Oncologists: A Society Of Gynecologic Oncology Evidence-Based Review and Recommendations Obstetrical & Gynecological Survey ·Ilana Cass, Linda Duska, Stephanie V. Blank, Georgina Cheng, Nefertiti C. duPont, Peter J. Frederick, Emily K. Hill, Carolyn M. Matthews, Tarah Pua, Kellie S. Rath, R. Ruskin, Premal H. Thaker, Andrew Berchuck, Bobbie S. Gostout, David Kushner, J.M. Fowler	2016	10
18	Effects of cancer treatment on ovarian function Fertility and Sterility ·Jacob Stroud, David G. Mutch, Janet S. Rader, Matt Powell, Premal H. Thaker, Perry W. Grigsby	2008	68
19	Metronomic Chemotherapy Enhances the Efficacy of Antivascular Therapy in Ovarian Cancer Cancer Research ·Aparna A. Kamat, Tae Jin Kim, Charles N. Landen, Chunhua Lu, Liz Y. Han, Yvonne G. Lin, William M. Merritt, Premal H. Thaker, David M. Gershenson, Farideh Z. Bischoff, John V. Heymach, Robert B. Jaffe, Robert L. Coleman, Anil K. Sood	2007	113
20	Filter paper spot blood glucose. Laboratory and patient methodology Practical Diabetes International ·Gerald F. Watts, Premal H. Thaker, Pamela West, Ken Shaw	1985	5

About Premal H. Thaker

Premal H. Thaker is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Behavioral Neuroscience and Cancer Research, having authored 283 papers that have together received 5.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (85 papers), Endometrial and Cervical Cancer Treatments (83 papers), Cervical Cancer and HPV Research (25 papers), Cancer, Stress, Anesthesia, and Immune Response (20 papers), Cancer survivorship and care (20 papers), Uterine Myomas and Treatments (18 papers), Intraperitoneal and Appendiceal Malignancies (15 papers) and PARP inhibition in cancer therapy (15 papers). The work is most often cited by research in Obstetrics and Gynecology (1.3k citations), Reproductive Medicine (1.1k citations), Behavioral Neuroscience (283 citations), Oncology (1.8k citations) and Psychiatry and Mental health (829 citations). Premal H. Thaker has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Anil K. Sood, David G. Mutch, Susan K. Lutgendorf, Matthew A. Powell, Israel Zighelboim, Charles N. Landen, L. Stewart Massad, Steve W. Cole, Liz Y. Han and Aparna A. Kamat. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, International Journal of Gynecological Cancer, Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact